Response to Eriksson et al A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients

Transpl Infect Dis. 2021 Apr;23(2):e13493. doi: 10.1111/tid.13493. Epub 2020 Oct 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Kidney Transplantation* / adverse effects
  • Pneumococcal Infections* / prevention & control
  • Polysaccharides
  • Transplant Recipients
  • Vaccination

Substances

  • Polysaccharides

Grants and funding